Neurotrophic theories of stress and neurobiology of antidepressants: Applications in psycho-oncology;Théories neurotrophiques du stress et neurobiologie des antidépresseurs: Applications en psycho-oncologie

Bulletin du Cancer

Volumn 94, Issue 5, 2007, Pages 431-438

  Ronson, Alain ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Antidepressants; Cancer; Information processing; Neurogenesis; Psychological stress

Indexed keywords

ANTIDEPRESSANT AGENT; NORADRENALIN; SEROTONIN;

ANXIETY DISORDER; CANCER PATIENT; CENTRAL NERVOUS SYSTEM; CHRONIC STRESS; GENE EXPRESSION; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL STRESS; NERVOUS SYSTEM DEVELOPMENT; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PSYCHOTHERAPY; REVIEW; SIGNAL TRANSDUCTION; METHODOLOGY; NEUROBIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL;

ANTIDEPRESSIVE AGENTS; HUMANS; MODELS, PSYCHOLOGICAL; NEUROBIOLOGY; STRESS, PSYCHOLOGICAL;

EID: 34250681378     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2007.0235     Document Type: Review

References (46)

1. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983 ; 249 : 751-7.
2. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004 ; 32 : 57-71.
3. Kangas M, Henry JL, Bryant RA. Posttraumatic stress disorder following cancer. A conceptual and empirical review. Clin Psychol Rev 2002 ; 22 : 499-524.
4. Grabsch B, Clarke DM, Love A, McKenzie DP, Snyder RD, Bloch S, et al. Psychological morbidity and quality of life in women with advanced breast cancer : a cross-sectional survey. Palliat Support Care 2006 ; 4 : 47-56.
5. Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breasr cancer. Cancer 2006 ; 107 : 2924-31.
6. Mehnert A, Koch U. Prevalence of acute and post-traumatic sttess disorder and comorbid mental disorders in breast cancer patients during primary cancer care : a prospective study. Psychooncology 2007 ; 16 : 181-8.
7. Pandey M, Sarita GP, Devi N, Thomas BC, Hussain BM, Krishnan R. Distress, anxiety, and depression in cancer patients undergoing chemotherapy. World J Surg Oncol 2006 ; 4 : 68.
8. Sharpley CF, Christie DR. An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer. Psychooncology 2006 ; [Epub ahead of print].
9. Pandey M, Devi N, Thomas BC, Vinod Kumar S, Krishnan R, Ramdas K. Distress overlaps with anxiety and depression in patients with head and neck cancer. Psychooncology 2006 [Epub ahead of print].
10. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer : a systematic review. Br J Cancer 2006 ; 94 : 372-90.
11. Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK, et al. The treatment of depression in cancer patients : a systematic review. Support Care Cancer 2007 ; 15 : 123-36.
12. Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, et al. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 2006 ; 6 : 288-96.
13. Ronson A. Stress et charge allostatique: perspectives en psychooncologie. Bull Cancer 2006 ; 93 : 289-95.
14. Ronson A. Stress psychologique en oncologie : le rôle des glucocorticoides. Bull Cancer 2006 ; 93 : 699-708.
15. Carlsson A. The contribution of drug research to investigating the nature of endogenous depression. Pharmakopsychiatr Neuropsychopharmakol 1976 ; 9 : 2-10.
16. Blendy JA. The role of CREB in depression and antidepressant treatment. Biol Psychiatry 2006 ; 59 : 1144-50.
17. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006 ; 59 : 1116-27.
18. Castren E. Is mood chemistry? Nat Rev Neurosci 2005 ; 6 : 241-6.
19. McEwen BS. The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective. Psychiatr Clin North Am 2002 ; 25 : 469-94.
20. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants : a critical overview. Pharmacol Rev 2006 ; 58 : 115-34.
21. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002 ; 35 : 605-23.
22. Malberg JE, Blendy JA. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 2005 ; 26 : 631-8.
23. Huang GJ, Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol Psychiatry 2006 ; 59 : 619-24.
24. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003 ; 301 : 805-9.
25. Manier DH, Shelton RC, Ellis TC, Peterson CS, Eiring A, Sulser F. Human fibroblasts as a relevant model to study signal transduction in affective disorders. J Affect Disord 2000 ; 61 : 51-8.
26. Koch JM, Kell S, Hinze-Selch D, Aldenhoff JB. Changes in CREB-phosphorylation during recovery from major depression. J Psychiatr Res 2002 ; 36 : 369-75.
27. Zubenko GS, Hughes HB, Maher BS, Stiffler JS, Zubenko WN, et al. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet 2002 ; 114 : 980-7.
28. Castren E. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 2004 ; 4 : 58-64.
29. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002 ; 34 : 13-25.
30. Sapolsky RM. Stress, glucocorticoids, and damage to the nervous system : the current state of confusion. Stress 1996 ; 1 : 1-19.
31. Newton SS, Duman RS. Regulation of neurogenesis and angiogenesis in depression. Curr Neurovasc Res 2004 ; 1 : 261-7.
32. Duman RS, Vaidya VA. Molecular and cellular actions of chronic electro-convulsive seizures. J ECT 1998 ; 14 : 181-93.
33. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 : 1256-60.
34. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, et al. BDNF variation and mood disorders : a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005 ; 30 : 1353-61.
35. Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T, et al. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 2005 ; 79 : 756-71.
36. Bremner JD, Vermetten E. Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder. Ann N Y Acad Sci 2004 ; 1032 : 154-7.
37. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe : potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004 ; 28 : 559-76.
38. Gonzalez-Perez A, Garcia Rodriguez LA. Breast cancer risk among users of antidepressant medications. Epidemiology 2005 ; 16 : 101-5.
39. Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR. Antidepressant use and breast cancer risk. Breast Cancer Res Treat 2006 ; 95 : 131-40.
40. Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Antidepressant medication use and risk of ovarian cancer. Obstet Gynecol 2005 ; 105 : 725-30.
41. Xu W, Tamim H, Shapiro S, Stang MR, Collet JP. Use of antidepressants and risk of colorectal cancer : a nested case-control study. Lancet Oncol 2006 ; 7 : 301-8.
42. Bahl S, Cotterchio M, Kreiger N, Klar N. Antidepressant medication use and non-Hodgkin's lymphoma risk : no association. Am J Epidemiol 2004 ; 160 : 566-75.
43. Peer D, Margalit R. Fluoxetine and reversal of multidrug resistance. Cancer Lett 2006 ; 237 : 180-7.
44. Castren E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007 ; 7 : 18-21.
45. Segev I. What do dendrites and their synapses tell the neuron? J Neurophysiol 2006 ; 95 : 1295-7.
46. Edelman GM. Naturalizing consciousness : a theoretical framework. Proc Natl Acad Sci USA 2003 ; 100 : 5520-4.